Attach to Form 990 or Form 990-EZ.
Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
| (i)Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| Total | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | 174,658,160 | 159,779,664 | 118,656,952 | 91,606,572 | 77,337,857 | 622,039,205 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | 0 | 0 | 0 | 0 | ||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | 0 | 0 | 0 | ||
| 4 | Total. Add lines 1 through 3 | 174,658,160 | 159,779,664 | 118,656,952 | 91,606,572 | 77,337,857 | 622,039,205 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 8,917,603 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 613,121,602 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 174,658,160 | 159,779,664 | 118,656,952 | 91,606,572 | 77,337,857 | 622,039,205 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 3,812,083 | 4,528,150 | 4,810,808 | 4,064,746 | 3,542,123 | 20,757,910 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 84,038 | 378,313 | 351,342 | 436,740 | 153,632 | 1,404,065 |
| 11 | Total support Add lines 7 through 10. | 644,201,180 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e | Discount claimed for blockage or other factors (explain in detail in Part VI): | |||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| 7 | Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions) | |||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2014 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2014 |
(iii) Distributable Amount for 2014 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2014 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2014 (reasonable cause required--see instructions) |
||||
| 3 Excess distributions carryover, if any, to 2014: | ||||
| a From 2009.......X | ||||
| b From 2010.......X | ||||
| c From 2011.......X | ||||
| d From 2012.......X | ||||
| e From 2013....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2014 distributable amount | ||||
|
i
Carryover from 2009 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2014 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2014 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2014, if any. Subtract lines 3g and 4a from line 2 (if amount greater than zero, see instructions) |
||||
|
6
Remaining underdistributions for 2014. Subtract lines 3h and 4b from line 1 (if amount greater than zero, see instructions) |
||||
|
7 Excess distributions carryover to 2015. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a From 2010.......X | ||||
| b From 2011.......X | ||||
| c From 2012.......X | ||||
| d From 2013....... | ||||
| e From 2014....... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Information about Schedule O (Form 990 or 990-EZ) and its instructions is at| Return Reference | Explanation |
|---|---|
| Volunteers | FORM 990, PART I, QUESTION 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS THE WORLD'S LARGEST BREAST CANCER ORGANIZATION, FUNDING MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT WHILE PROVIDING REAL-TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $889 MILLION IN RESEARCH AND PROVIDED $1.9 BILLION IN FUNDING TO SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 30 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. A - Research SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO COUNTLESS MAJOR ADVANCES IN BREAST CANCER SCIENCE. IN JUST ONE GENERATION, THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE DESIGNED TO UNDERSTAND THE BIOLOGY OF BREAST CANCER AND ADVANCE THE TRANSLATION OF RESEARCH DISCOVERIES INTO NEW WAYS TO DETECT, DIAGNOSE, TREAT, AND PREVENT BREAST CANCER, IN ORDER TO REDUCE BREAST CANCER INCIDENCE AND MORTALITY WITHIN THE NEXT DECADE. TO ENSURE MAXIMUM IMPACT, Komen calls on its Mission Advisors-the best and brightest breast cancer researchers, clinicians, advocates and other experts- to help guide and implement our mission programs. Thanks to their efforts, we're driving discovery, affecting change and accelerating progress in the fight against breast cancer. The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs, and plays a key role in guiding and prioritizing Komen's global research investment. The SAB is led by the chief scientific advisors and serves as the executive committee of the Komen Scholars. The Komen Scholars are an advisory group of 60 distinguished leaders in breast cancer research and advocacy. Representing more than 32 institutions in seven countries, their expertise includes clinical research, laboratory research, pathology, prevention, radiation oncology, surgery and other disciplines and specialties. They contribute to our programs, activities and events in many ways-most notably by leading and participating as reviewers in our scientific peer review process - and act as our ambassadors in communities around the U.S. and the world. Komen's research advocates, Advocates In Science (AIS), bring the patient voice to research, ensuring that the unique and valuable perspectives of breast cancer patients, survivors, and co-survivors are integrated into the scientific dialogue and decisions that impact progress toward ending breast cancer. Komen uniquely includes AIS in every step of the research investment process: They serve on our Scientific Advisory Board and Komen Scholars; participate in research grant peer reviews; work with or as part of scientific teams to help prioritize, develop and implement research projects; and educate our Affiliates and the public to enhance community awareness, understanding, and support of breast cancer research. KOMEN RESEARCH AND TRAINING PROGRAM: KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS AND ORGANIZATIONS AROUND THE WORLD THROUGH A TRANSPARENT AND RIGOROUS PEER REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH DOLLARS. OUR SCIENTIFIC ADVISORY BOARD DETERMINES THE MOST CRITICAL AREAS OF NEED IN BREAST CANCER RESEARCH. THESE NEEDS DETERMINE THE AREAS OF RESEARCH FOCUS IN THE REQUEST FOR APPLICATIONS (RFA). THE RFA IS ANNOUNCED AND RESEARCHERS SUBMIT SHORT VERSIONS OF THEIR PROPOSALS, DESCRIBING BOTH THE PROPOSED STUDY AND POTENTIAL CLINICAL IMPACT OF THE PROJECT. THESE PRE-APPLICATIONS ARE SCIENTIFICALLY REVIEWED BY PEER-REVIEW COMMITTEES WHICH ARE LED BY A CHAIRPERSON AND COMPRISED OF OUR KOMEN SCHOLARS, ADVOCATES IN SCIENCE AND OTHER PROMINENT RESEARCHERS AND ADVOCATES FROM AROUND THE GLOBE. APPROXIMATELY 20-25 PERCENT OF THESE PRE-APPLICATIONS WILL BE IDENTIFIED AS THE MOST MERITORIOUS AND ALIGNED WITH OUR RESEARCH OBJECTIVES. UPON APPROVAL BY OUR SCIENTIFIC ADVISORY BOARD, APPLICANTS WILL BE INVITED TO SUBMIT FULL APPLICATIONS FOR FURTHER PEER REVIEW AND FUNDING CONSIDERATION. FULL APPLICATIONS ARE DISCUSSED, RATED AND SCORED BY THE ASSIGNED REVIEWERS - INCLUDING MEMBERS OF THE KOMEN SCHOLARS AND ADVOCATES IN SCIENCE- WHO ASSESS THE STRENGTHS AND WEAKNESSES OF EACH APPLICATION BASED ON DEFINED REVIEW CRITERIA SUCH AS SCIENTIFIC MERIT AND POTENTIAL FOR IMPACT. THE OVERALL SCORES FOR EACH APPLICATION ARE THEN USED BY THE SCIENTIFIC ADVISORY BOARD TO MAKE FINAL FUNDING RECOMMENDATIONS ACROSS ALL RESEARCH MECHANISMS. APPLICATIONS ARE RECOMMENDED FOR FUNDING IN THE ORDER OF THE OVERALL AVERAGE SCORE. THE SCIENTIFIC ADVISORY BOARD'S RECOMMENDATIONS ARE FORWARDED TO KOMEN LEADERSHIP, WHO APPROVE THE FINAL SLATE OF APPLICATIONS FOR FUNDING. THE BOARD OF DIRECTORS APPROVES THE ANNUAL BUDGET FOR KOMEN, WHICH INCLUDES THE TOTAL BUDGET FOR GRANTS. THE BOARD OF DIRECTORS HOLDS THE RESPONSIBILITY OF REVIEWING THE FINANCIAL HEALTH OF THE ORGANIZATION AND APPROVING ANY REDUCTIONS OR INCREASES IN THE TOTAL MISSION BUDGET FOR GRANTS. PEER-REVIEW IS A GRANT REVIEW PROCESS USED BY MANY ORGANIZATIONS, INCLUDING THE NATIONAL INSTITUTES OF HEALTH (NIH), TO DETERMINE WHICH RESEARCH GRANTS WILL BE FUNDED. IN FACT, THE NIH HAS DESIGNATED, PER PROGRAM ANNOUNCEMENT STANDARD NUMBER PAR-13-386, THAT KOMEN MAINTAINS A PEER REVIEW SYSTEM THAT IS FREE OF CONFLICTS OF INTEREST AND THAT BASES DECISIONS ON SCIENTIFIC MERIT. BY USING THIS RIGOROUS PROCESS, WE STRIVE TO FUND THE VERY BEST RESEARCH - FUNDING PROJECTS THAT HAVE THE POTENTIAL TO ADVANCE THE FIELD AND HAVE AN IMPACT ON PATIENTS AS RAPIDLY AS POSSIBLE. A TYPICAL PEER-REVIEW PROCESS CAN INVOLVE MORE THAN 400 SCIENTISTS AND ADVOCATE REVIEWERS AND UP TO 23 TO 25 PEER-REVIEW COMMITTEES. ALTHOUGH THE NUMBER OF APPLICATIONS RECEIVED VARIES FROM YEAR TO YEAR, KOMEN TYPICALLY RECEIVES BETWEEN 950 AND 1,050 PRE-APPLICATIONS ANNUALLY. FUNDING RATIOS CAN VARY CONSIDERABLY BY YEAR AND GRANT TYPE. IN FISCAL YEAR 2015, KOMEN AWARDED 124 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, BRAZIL, CANADA, ISRAEL, ITALY, JORDAN, MEXICO, PANAMA, SPAIN AND SWITZERLAND. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, WE CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS FOR LACK OF FUNDING. TO THAT END, THE FOLLOWING REQUEST-FOR-APPLICATIONS (RFA) GRANT OPPORTUNITIES WERE OFFERED BY KOMEN DURING FISCAL YEAR 2015: POSTDOCTORAL FELLOWSHIPS (PDF): PDF GRANTS SEEK TO ATTRACT AND SUPPORT PROMISING SCIENTISTS EMBARKING ON CAREERS DEDICATED TO BREAST CANCER RESEARCH WHO HAVE NO MORE THAN 3 YEARS POST-COMPLETION OF THEIR MOST RECENT CLINICAL FELLOWSHIP, 5 YEARS POST-COMPLETION OF THEIR MOST RECENT RESIDENCY (FOR PHYSICIANS) OR 5 YEARS POST-COMPLETION OF THEIR MOST RECENT PHD. BY PROVIDING FUNDING TO OUTSTANDING POSTDOCTORAL/POSTGRADUATE FELLOWS UNDER THE GUIDANCE OF A MENTOR, KOMEN SEEKS TO ENSURE THAT A DIVERSE POOL OF HIGHLY TRAINED SCIENTISTS WILL EMERGE AS THE NEXT GENERATION OF LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. PDF GRANTS PROVIDE SUPPORT FOR RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. GRADUATE TRAINING IN DISPARITIES RESEARCH (GTDR): GTDR GRANTS (FORMERLY POST-BACCALAUREATE TRAINING IN DISPARITIES RESEARCH GRANTS) ARE INTENDED TO ESTABLISH AND/OR TO SUSTAIN A TRAINING PROGRAM DEDICATED TO UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES ACROSS POPULATION GROUPS. AT LEAST THREE GRADUATE STUDENTS, PREFERABLY THOSE from populations affected by disparities in breast cancer outcomes, ARE SUPPORTED. CAREER CATALYST RESEARCH (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN SIX YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. CCR GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. KOMEN'S RESEARCH INVESTMENT THROUGH THE ABOVE GRANT MECHANISMS SUPPORT PROJECTS THAT AIM TO, |
| Executive Committee | FORM 990, PART VI, LINE 1A The Organization's Bylaws provide for an Executive Committee comprised of a minimum of five members including the Board Chair, the President and Chief Executive Officer, and additional Board members, as recommended by the Governance Committee and appointed by the Board of Directors. Members of the Executive Committee must either be Directors of the Organization or the President and Chief Executive Officer. The Bylaws provide that the Executive Committee has the power to (a) appoint members to non-standing committees of the Organization, and name chairs of such committees; (b) authorize unbudgeted disbursements by the Organization in accordance with the specific expenditure authority prescribed by the Board of Directors; (c) employ agents; and (d) carry into execution such other measures as it determines will promote the purpose of the Organization. The committee also may exercise, when the board is not in session, all of the authority of the board in the management of the business and affairs of the organization with certain exceptions such as repealing any board resolutions, amending the organization's articles or bylaws, or merging or dissolving the organization. This delegation does not relieve the board of any of its responsibilities imposed by law, and the committee endeavors to limit its exercise of authority to time sensitive issues. SIGNIFICANT CHANGES TO GOVERNING DOCUMENTS FORM 990, PART VI, QUESTION 4 SIGNIFICANT CHANGES during fiscal year 2015: - Established the minimum/maximum number of directorships at 7/13 - Established a minimum/maximum total for Class III directors (minimum of two and a maximum of three) and Class IV directors (minimum of 3 and maximum of 9), but never more than 13 total - Increased term limits for (a) Class III directors to a single 3-year term and (b) Class IV directors to two consecutive 3-year terms - Allowed for Class III and IV directors to take a leave of absence for no more than 6 months and allowed for the board to appoint an interim Class IV director during the period of the leave of any director - Recognized that the chair will act as the tiebreaking vote in the event of a deadlock in a board vote - Clarified that filling a vacancy on the board is not counted as a term - Clarified that, for Class IV directors, a second term is possible but not assured - Clarified the parameters and term limits associated with board election of directors to fill vacant directorships between annual meetings - Revised the committee terms for appointment of director members (annually appointed) and non-director members (biennially appointed) and clarified that committee appointments take place at the annual meeting - Clarified that there are both voting and non-voting ex officio appointments to committees - Added a Class III director to those board members required to serve on the Executive Committee (also allowed for the discretional appointment of Class IV director(s) to the Executive Committee) - Permitted the President & CEO to appoint non-director officers without an amendment to the Bylaws DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVELS OF MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND MAKES AN APPROVAL RECOMMENDATION REGARDING THE FORM 990 TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS APPROVES THE FORM 990 PRIOR TO THE FORM BEING FILED. DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTEREST FORM 990, PART VI, QUESTION 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARDS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY CONFLICTS ARE THEN REVIEWED BY MANAGEMENT AND THE AUDIT COMMITTEE AND APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARDS ARE REQUIRED TO UPDATE THEIR CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. OFFICES & POSITIONS FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS BEGUN FORM 990, PART VI, QUESTIONS 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE PRESIDENT/CHIEF EXECUTIVE OFFICER, THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER EMPLOYEES, GRANTING THE CEO AUTHORITY TO DETERMINE ACTUAL COMPENSATION LEVELS WITHIN AN APPROVED RANGE, AND INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. FOR THE POSITIONS OF PRESIDENT/CEO AND FOUNDER/CHAIR OF GLOBAL STRATEGY, EXTERNAL BENCHMARKING WAS CONDUCTED TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO GEN PUBLIC FORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE, AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 IS NOT ONLINE BUT IS AVAILABLE TO THE PUBLIC UPON REQUEST. ADDITIONAL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXP FORM 990, PART IX, LINE 24 Komen pays 80% of the cost of all T-shirts for the 138 Susan G. Komen race for the cure events conducted by the Komen Affiliates during the year. OTHER CHANGES IN NET ASSETS OR FUND BALANCES FORM 990, PART XI, LINE 9 RESCINDED GRANTS - $7,202,135 |
| Software ID: | |
| Software Version: |